J 2021

Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology

HOENIGL, M., J. SALMANTON-GARCIA, T. J. WALSH, M. NUCCI, C. F. NEOH et. al.

Basic information

Original name

Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology

Authors

HOENIGL, M. (guarantor), J. SALMANTON-GARCIA, T. J. WALSH, M. NUCCI, C. F. NEOH, J. D. JENKS, M. LACKNER, R. SPRUTE, A. M. S. AL-HATMI, M. BASSETTI, F. CARLESSE, Tomáš FREIBERGER (203 Czech Republic, belonging to the institution), P. KOEHLER, T. LEHRNBECHER, A. KUMAR, J. PRATTES, M. RICHARDSON, S. REVANKAR, M. A. SLAVIN, J. STEMLER, B. SPIESS, S. J. TAJ-ALDEEN, A. WARRIS, P. C. Y. WOO, J. A. H. YOUNG, K. ALBUS, D. ARENZ, V. ARSIC-ARSENIJEVIC, J. P. BOUCHARA, T. R. CHINNIAH, A. CHOWDHARY, G. S. DE HOOG, G. DIMOPOULOS, R. F. DUARTE, P. HAMAL, J. F. MEIS, S. MFINANGA, F. QUEIROZ-TELLES, T. F. PATTERSON, G. RAHAV, T. R. ROGERS, C. ROTSTEIN, R. WAHYUNINGSIH, D. SEIDEL and O. A. CORNELY

Edition

Lancet Infectious Diseases, Oxford, Elsevier SCI LTD, 2021, 1473-3099

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30303 Infectious Diseases

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 71.421

RIV identification code

RIV/00216224:14110/21:00123978

Organization unit

Faculty of Medicine

UT WoS

000680046200004

Keywords in English

rare mould infections; diagnosis; management

Tags

Tags

International impact, Reviewed
Změněno: 29/3/2022 12:42, Mgr. Tereza Miškechová

Abstract

V originále

With increasing numbers of patients needing intensive care or who are immunosuppressed, infections caused by moulds other than Aspergillus spp or Mucorales are increasing. Although antifungal prophylaxis has shown effectiveness in preventing many invasive fungal infections, selective pressure has caused an increase of breakthrough infections caused by Fusarium, Lomentospora, and Scedosporium species, as well as by dematiaceous moulds, Rasamsonia, Schizophyllum, Scopulariopsis, Paecilomyces, Penicillium, Talaromyces and Purpureocillium species. Guidance on the complex multidisciplinary management of infections caused by these pathogens has the potential to improve prognosis. Management routes depend on the availability of diagnostic and therapeutic options. The present recommendations are part of the One World-One Guideline initiative to incorporate regional differences in the epidemiology and management of rare mould infections. Experts from 24 countries contributed their knowledge and analysed published evidence on the diagnosis and treatment of rare mould infections. This consensus document intends to provide practical guidance in clinical decision making by engaging physicians and scientists involved in various aspects of clinical management. Moreover, we identify areas of uncertainty and constraints in optimising this management.